Class information for:
Level 1: LOW DENSITY LIPOPROTEIN LDL RECEPTORS//ATHEROGENIC MICE//BIOCHEM BIOPHYS S

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
19788 425 36.2 71%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
56 28576 CHOLESTERYL ESTER TRANSFER PROTEIN//JOURNAL OF LIPID RESEARCH//HIGH DENSITY LIPOPROTEIN

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 LOW DENSITY LIPOPROTEIN LDL RECEPTORS Author keyword 9 83% 1% 5
2 ATHEROGENIC MICE Author keyword 8 100% 1% 5
3 BIOCHEM BIOPHYS S Address 6 100% 1% 4
4 MACROPHAGES AND FOAM CELLS Author keyword 6 100% 1% 4
5 ATHEROSCLEROSIS TREATMENT Author keyword 3 60% 1% 3
6 DEXAMETHASONE PALMITATE Author keyword 2 36% 1% 5
7 RECONSTITUTED HIGH DENSITY LIPOPROTEINS Author keyword 2 67% 0% 2
8 AUTOLOGOUS LOW DENSITY LIPOPROTEIN LABELING Author keyword 1 50% 0% 2
9 LIPOPROTEIN COMPLEXES Author keyword 1 100% 0% 2
10 LOW DENSITY LIPOPROTEIN LABELING Author keyword 1 100% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 LOW DENSITY LIPOPROTEIN LDL RECEPTORS 9 83% 1% 5 Search LOW+DENSITY+LIPOPROTEIN+LDL+RECEPTORS Search LOW+DENSITY+LIPOPROTEIN+LDL+RECEPTORS
2 ATHEROGENIC MICE 8 100% 1% 5 Search ATHEROGENIC+MICE Search ATHEROGENIC+MICE
3 MACROPHAGES AND FOAM CELLS 6 100% 1% 4 Search MACROPHAGES+AND+FOAM+CELLS Search MACROPHAGES+AND+FOAM+CELLS
4 ATHEROSCLEROSIS TREATMENT 3 60% 1% 3 Search ATHEROSCLEROSIS+TREATMENT Search ATHEROSCLEROSIS+TREATMENT
5 DEXAMETHASONE PALMITATE 2 36% 1% 5 Search DEXAMETHASONE+PALMITATE Search DEXAMETHASONE+PALMITATE
6 RECONSTITUTED HIGH DENSITY LIPOPROTEINS 2 67% 0% 2 Search RECONSTITUTED+HIGH+DENSITY+LIPOPROTEINS Search RECONSTITUTED+HIGH+DENSITY+LIPOPROTEINS
7 AUTOLOGOUS LOW DENSITY LIPOPROTEIN LABELING 1 50% 0% 2 Search AUTOLOGOUS+LOW+DENSITY+LIPOPROTEIN+LABELING Search AUTOLOGOUS+LOW+DENSITY+LIPOPROTEIN+LABELING
8 LIPOPROTEIN COMPLEXES 1 100% 0% 2 Search LIPOPROTEIN+COMPLEXES Search LIPOPROTEIN+COMPLEXES
9 LOW DENSITY LIPOPROTEIN LABELING 1 100% 0% 2 Search LOW+DENSITY+LIPOPROTEIN+LABELING Search LOW+DENSITY+LIPOPROTEIN+LABELING
10 REMODELING BEHAVIORS 1 100% 0% 2 Search REMODELING+BEHAVIORS Search REMODELING+BEHAVIORS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANTITUMORAL DRUGS 38 86% 4% 19
2 LABELED LDL 20 100% 2% 9
3 P388 LEUKEMIC CELLS 14 100% 2% 7
4 CHOLESTEROL RICH MICROEMULSION 13 67% 3% 12
5 MICROEMULSION LDE 8 100% 1% 5
6 PLASMA KINETICS 8 33% 4% 19
7 CHOLESTEROL RICH EMULSION 6 80% 1% 4
8 PEPTIDE LIPID NANOPARTICLES 4 75% 1% 3
9 LDE 3 100% 1% 3
10 RECOMBINANT LIPOPROTEINS 2 67% 0% 2

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Lipoprotein-Inspired Nanoparticles for Cancer Theranostics 2011 66 48 50%
Synthetic high-density lipoprotein-like nanoparticles for cancer therapy 2015 1 68 31%
LOW-DENSITY-LIPOPROTEIN AS A VEHICLE FOR TARGETING ANTITUMOR COMPOUNDS TO CANCER-CELLS 1994 132 129 33%
Phospholipid nanodisc engineering for drug delivery systems 2012 10 54 26%
Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs 2007 26 95 41%
The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics 2013 16 68 19%
Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs 2014 1 59 44%
Evaluation in melanoma-bearing mice of an etoposide derivative associated to a cholesterol-rich nanoemulsion 2006 8 16 50%
UPTAKE OF LOW-DENSITY-LIPOPROTEIN BY MALIGNANT-CELLS - POSSIBLE THERAPEUTIC APPLICATIONS 1991 53 49 43%
Modified natural nanoparticles as contrast agents for medical imaging 2010 58 101 12%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 BIOCHEM BIOPHYS S 6 100% 0.9% 4
2 BIOMED MFG TECHNOL 1 50% 0.2% 1
3 METAB LIPIDES CORACAO 1 50% 0.2% 1
4 MOL INTERVENT CARDIOVASC DIS 1 50% 0.2% 1
5 PHARMACOL SCI VIA BALZARETTI 9 1 50% 0.2% 1
6 TUMOR BIOL CORE 1 50% 0.2% 1
7 METAB LIPIDES 1 13% 0.9% 4
8 HLTH SCI PERMIAN BASIN 0 20% 0.5% 2
9 CECIL H IDA GREEN REPRODUCT BIOL SCI 0 33% 0.2% 1
10 BIOL CELLULAIRE MOL EPITHELIUMS 0 17% 0.5% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000172446 ASSOC CARDIAC//ASSOC RIC CARDIOL//CLIN EXPT MED 2
2 0.0000115487 SR BI//SELECTIVE UPTAKE//HDL RECEPTOR
3 0.0000083667 TOXICOL STUDIES//METAB NUTR INTERACT//ALCOHOL ACTION
4 0.0000070633 IMAGING SCI S//VESSEL WALL IMAGING//TRANSLAT MOL IMAGING
5 0.0000067578 RICE FALSE SMUT//USTILAGINOIDEA VIRENS//RHIZOXIN
6 0.0000066569 APOLIPOPROTEIN A I//REVERSE CHOLESTEROL TRANSPORT//APOLIPOPROTEIN A II
7 0.0000066058 SCAVENGER RECEPTOR//FRACTIONATED H 3HEPARIN//CLASS A SCAVENGER RECEPTOR
8 0.0000064049 HUMAN LIFE CULTURE//DDT DDT//PENTACHLOROBENZENE
9 0.0000063737 PHARMACEUT MED BIOTECHNOL//EQUIPE PHARM BIOGALEN//EQUIPE GENIE PHARMACOTECH
10 0.0000062866 PHOTOCHEMICAL INTERNALIZATION//PHOTOCHEMICAL INTERNALISATION//CANC STEM CELL INNOVAT SFI CAST